Zusammenfassung
Der Lichen sclerosus ist eine chronische, entzündliche Hauterkrankung, die meist den Genitalbereich betrifft. Die frühe Diagnose und anschließende, dauerhafte antientzündliche Behandlung können die Krankheit so beeinflussen, dass Patienten weitgehend symptomfrei sind und das Risiko von mutierenden Krankheitsverläufen und der Karzinomentwicklung reduziert ist.
Abstract
Lichen sclerosus is a chronic, inflammatory dermatosis that usually affects the anogenital area. Early diagnosis and subsequent long-term anti-inflammatory treatment may reduce symptoms and signs and the risk of a mutilating course and the development of carcinomas.
Literatur
Cooper SM, Gao XH, Powell JJ, Wojnarowska F (2004) Does treatment of vulvar lichen sclerosus influence its prognosis? Arch Dermatol 140:702–706
Casey GA, Cooper SM, Powell JJ (2015) Treatment of vulvar lichen sclerosus with topical corticosteroids in children: a study of 72 children. Clin Exp Dermatol 40:289–292
Lee A, Bradford J, Fischer G (2015) Long-term management of adult vulval lichen sclerosus. A prospective cohort study of 507 women. JAMA Dermatol 151:1061–1067
Kirtschig G, Becker K, Günthert A et al (2015) Evidence-based (S3) guideline on (anogenital) lichen sclerosus. J Eur Acad Dermatol Venereol 29:e1–e43
Tong LX, Sun GS, Teng JM (2015) Pediatric lichen sclerosus: a review of the epidemiology and treatment options. Pediatr Dermatol 32:593–599
Wallace HJ (1971) Lichen sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc 57:9–30
Tasker GL, Wojnarowska F (2003) Lichen sclerosus. Clin Exp Dermatol 28:128–133
Günthert AR, Faber M, Knappe G, Hellriegel S, Emons G (2008) Early onset vulvar lichen sclerosus in premenopausal women and oral contraceptives. Eur J Obstet Gynecol Reprod Biol 137:56–60
Powell J, Wojnarowska F (2002) Childhood vulvar lichen sclerosus. The course after puberty. J Reprod Med 47:706–709
Kizer WS, Prarie T, Morey AF (2003) Balanitis xerotica obliterans: epidemiologic distribution in an equal access health care system. South Med J 96:9–11
Edmonds EV, Hunt S, Hawkins D et al (2012) Clinical parameters in male genital lichen sclerosus: a case series of 329 patients. J Eur Acad Dermatol Venereol 26:730–737
Terlou A, Santegoets LA, van der Meijden WI et al (2012) An autoimmune phenotype in vulvar lichen sclerosus and lichen planus: a Th1 response and high levels of microRNA-155. J Invest Dermatol 132:658–666
Feig JL, Gribetz ME, Lebwohl MG (2016) Chronic lichen sclerosus successfully treated with intralesional adalimumab. Br J Dermatol 174:687–689
Lowenstein EB, Zeichner JA (2013) Intralesional adalimumab for the treatment of refractory balanitis xerotica obliterans. JAMA Dermatol 149:23–24
Sherman V, McPherson T, Baldo M et al (2010) The high rate of familial lichen sclerosus suggests a genetic contribution: an observational cohort study. J Eur Acad Dermatol Venereol 24:1031–1034
Kirtschig G, Kuik DJ (2014) A Dutch cohort study confirms familial occurrence of anogenital lichen sclerosus. J Womens Health Care 3:6
Marren P, Yell J, Charnock FM et al (1995) The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol 132:197–203
Powell J, Wojnarowska F, Winsey S, Marren P, Welsh K (2000) Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol 142:481–484
Cooper SM, Ali I, Baldo M, Wojnarowska F (2008) The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol 144:1432–1435
Becker K, Meissner V, Farwick W, Bauer R, Gaiser MR (2013) Lichen sclerosus and atopy in boys: coincidence or correlation? Br J Dermatol 168:362–366
Powell JJ, Wojnarowska F (1999) Lichen sclerosus. Lancet 353:1777–1783
Bunker CB, Patel N, Shim TN (2013) Urinary voiding symptomatology (micro-incontinence) in male genital lichen sclerosus. Acta Derm Venereol 93:216–256
Kirtschig G (2016) Lichen sclerosus-presentation, diagnosis and management. Dtsch Arztebl Int 113:337–343
Becker K (2011) Lichen sclerosus in boys. Dtsch Ärztebl Int 108:53–58
Kostner S, EBM Service (2014) Phimose mit Talgretetionszyste. Z Allg Med 90:339–341
Rajagopalan R, Anderson RT, Sherertz EF et al (1999) Quality of life evaluation in chronic lichen sclerosus for improved medical care. Drug Inf J 33:577–584
Lansdorp CA, van den Hondel KE, Korfage IJ et al (2013) Quality of life in Dutch women with lichen sclerosus. Br J Dermatol 168:787–793
Burrows LJ, Creasey A, Goldstein AT (2011) The treatment of vulvar lichen sclerosus and female sexual dysfunction. J Sex Med 8:219–222
Dalziel KL (1995) Effect of lichen sclerosus on sexual function and parturition. J Reprod Med 40:351–354
Marin MG, King R, Dennerstein GJ et al (1998) Dyspareunia and vulvar disease. J Reprod Med 43:952–958
Schempp C, Bocklage H, Lange R, Kölmel HW, Orfanos CE, Gollnick H (1993) Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol 100:717–720
Edmonds E, Mavin S, Francis N et al (2009) Borrelia Burgdorferi is not associated with genital lichen sclerosus. Br J Dermatol 160:459–460
Drut RM, Gómez MA, Drut R, Lojo MM (1998) Human papillomavirus is present in some cases of childhood penile lichen sclerosus: an in situ hybridization and SP-PCR study. Pediatr Dermatol 15:85–90
Hald AK, Blaakaer J (2017) The possible role of human papillomavirus infection in the development of lichen sclerosus. Int J Dermatol. https://doi.org/10.1111/ijd.13697
Neill SM, Lewis FM, Tatnall FM, Cox NH (2010) British Association of Dermatologists. British Association of Dermatologists’ guidelines for the management of lichen sclerosus. Br J Dermatol 2010(163):672–682
Lewis FM, Tatnall FM, Velangi SS et al (2018) British Association of Dermatologists guidelines for the management of lichen sclerosus 2018. Br J Dermatol. https://doi.org/10.1111/bjd.16241
Niamh L, Naveen S, Hazel B (2009) Diagnosis of vulval inflammatory dermatoses: a pathological study with clinical correlation. Int J Gynecol Pathol 28:554–558
Kirtschig G, Gynecologic Dermatology CAS (2016) Symptoms, signs and clinical management, 1. Aufl. Jp Medical Ltd, London
Virgili A, Minghetti S, Borghi A, Corazza M (2013) Long-term maintenance therapy for vulvar lichen sclerosus: the results of a randomized study comparing topical vitamin E with an emollient. Eur J Dermatol 23:189–194
Simonart T, Lahaye M, Simonart J‑M (2008) Vulvar lichen sclerosus: effect of maintenance treatment with a moisturizer on the course of the disease. Menopause 15:74–77
D’Antuono A, Bellavista S, Negosanti F et al (2011) Dermasilk briefs in vulvar lichen sclerosus: an adjuvant tool. J Low Genit Tract Dis 15:287–291
Goldstein AT, Thac D, Luger T (2009) Topical calcineurin inhibitors for the treatment of vulvar dermatoses. Eur J Obstet Gynecol Reprod Biol 146:22–29
Mirastschijski U, Schwenke C, Melchior S, Buried Penis CC (2017) A comprehensive review on aetiology, classification and plastic-surgical reconstruction. Handchir Mikrochir Plast Chir 49:78–84
Stein R, Beetz R, Thüroff JW (2011) Kinderurologie in Klinik und Praxis, 3. Aufl. Thieme, Stuttgart. ISBN 978-3136748039
Rödder K, Olianas R, Fisch M (2006) Urethral strictures – operative strategy. Urologe A 45:499–511
Pandey A, Dican R, Beier J, Keller H (2014) Buccal mucosal graft in reconstructive urology: uses beyond urethral stricture. Int J Urol 21:732–734
Casabona F, Gambelli I, Casabona F et al (2017) Autologous platelet-rich plasma (PRP) in chronic penile lichen sclerosus: the impact on tissue repair and patient quality of life. Int Urol Nephrol 49:573–580
Goldstein AT, King M, Runels C et al (2017) Intradermal injection of autologous platelet-rich plasma for the treatment of vulvar lichen sclerosus. J Am Acad Dermatol 76:158–160
Lee A, Lim A, Fischer G (2016) Fractional carbon dioxide laser in recalcitrant vulval lichen sclerosus. Australas J Dermatol 57:39–43
Bradford J, Fischer G (2013) Surgical division of labial adhesions in vulvar lichen sclerosus and lichen planus. J Low Genit Tract Dis 17:48–50
Halonen P, Jakobsson M, Heikinheimo O et al (2017) Lichen sclerosus and risk of cancer. Int J Cancer 140:1998–2002
http://nottingham.ac.uk/research/groups/cebd/projects/5rareandother/ls-psp/index.aspx
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
G. Kirtschig gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine vom Autor durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Kirtschig, G. Lichen sclerosus. Hautarzt 69, 127–133 (2018). https://doi.org/10.1007/s00105-017-4121-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-017-4121-2